Delivery Order 75N93021D00035-75N93022F00002

Award Date 11/6/22
Potential Completion Date 8/31/25
Potential Value $83M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • 75N93021D00035
    Indefinite Delivery Contract
  • 75N93021D00035-75N93022F00002
    Delivery Order

This is a $82,531,927.00 delivery order awarded to PPD Development LP, a global contract research organization (CRO), by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for "COVID 19" COMPLETION OF ACTIV 2 STUDY and has an ultimate completion date of August 31, 2025. The contract type is cost-plus-fixed-fee, and there is no set-aside designation.

PPD Development LP is a subsidiary of Thermo Fisher Scientific and has extensive experience supporting federal agencies in clinical trial management, regulatory affairs, and research services for various public health initiatives and medical countermeasures. This award is likely part of NIAID's broader Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership, which is focused on developing COVID-19 treatments and vaccines through coordinated research efforts across government, industry, and academia.

Generated 10/30/24, 9:54 AM